Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Luminex Corporation    LMNX

Delayed Quote. Delayed  - 08/26 10:00:00 pm
21.2 USD   +0.57%
08/23 LUMINEX : FDA Continues EUA Allowances for Zika Diagnostics
08/13 LUMINEX : Top Local Business Stories of the Week
08/08 LUMINEX : Receives FDA Clearance for New Molecular Test for Identifi..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
21.84(c) 21.85(c) 21.18(c) 21.08(c) 21.2(c) Last
127 868 106 098 154 862 217 247 102 848 Volume
+0.69% +0.05% -3.07% -0.47% +0.57% Change
More quotes
Financials ($)
Sales 2016 266 M
EBIT 2016 39,7 M
Net income 2016 29,6 M
Debt 2016 -
Yield 2016 -
Sales 2017 294 M
EBIT 2017 42,4 M
Net income 2017 32,9 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 35,53
P/E ratio 2017 38,08
Capi. / Sales2016 3,47x
Capi. / Sales2017 3,14x
Capitalization 923 M
More Financials
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.Luminex was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. 
More about the company
Surperformance© ratings of Luminex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on LUMINEX CORPORATION
08/26 LUMINEX : Special Notice - Luminex xPONENT 4.2 Software
08/25 LUMINEX : Financial Statements and Exhibits (form 8-K/A)
08/23 LUMINEX : FDA Continues EUA Allowances for Zika Diagnostics
08/18 LUMINEX CORPORATION : Receives FDA Emergency Use Authorization for Zika Virus Mo..
08/13 LUMINEX : Top Local Business Stories of the Week
08/11 LUMINEX CORPORATION : Receives FDA Clearance for New Molecular Test for Identifi..
08/08 LUMINEX : Receives FDA Clearance for New Molecular Test for Identification and D..
08/05 LUMINEX : Assigned Patent
08/04 BRISTOL MYERS SQUIBB : New Findings from Bristol-Myers Squibb Describe Advances ..
08/03 LUMINEX : Reports Second Quarter 2016 Results
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
07/29DJSony Reports Surprise Profit
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
08/19 Healthcare ratings roundup - upgrades/downgrades
07/29 Luminex's (LMNX) CEO Homi Shamir on Q2 2016 Results - Earnings Call Transcrip..
07/28 Luminex beats by $0.18, beats on revenue
07/27 Notable earnings after Thursday?s close
07/06 Luminex receives FDA clearance and CE-IVD Mark for the ARIES M1 System
Advertisement
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Full-screen chart
Technical analysis trends LUMINEX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 22,0 $
Spread / Average Target 3,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Nachum Shamir President, Chief Executive Officer & Director
G. Walter Loewenbaum Chairman
Harriss T. Currie Chief Financial Officer, Treasurer & SVP-Finance
Thomas J. Copa Vice President-Technology & Strategic Partnerships
Charles J. Collins Vice President-Systems Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LUMINEX CORPORATION-0.89%923
THERMO FISHER SCIENTIF..7.41%60 070
BOSTON SCIENTIFIC CORP..29.99%32 617
PHILIPS10.29%27 591
INTUITIVE SURGICAL, IN..25.47%26 379
ILLUMINA, INC.-10.28%25 246
More Results